Sotac Pharmaceuticals Limited Share Price & Stock Analysis

Sotac Pharmaceuticals Limited (NSE: SOTAC) is an Ahmedabad, Gujarat-based company in the Pharmaceuticals industry. With a market capitalisation of ₹144 Cr, it ranks #2,939 by market cap among the 6,197 Indian listed companies on FinBizNet, and #42 of 63 in Pharmaceuticals. At ₹129.35 (as of 16 Nov 2026), the share price is 7.4% below its 52-week high of ₹139.65 and 50.4% above its 52-week low of ₹86.00. The share price is down 0.4% over one year and up 40.7% over three months.

Key Metrics

Current Price₹129.35
Market Cap₹144 Cr
NSE SymbolSOTAC
SectorHealth Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals
Sub-IndustryBiotechnology and Life Sciences > Pharmaceuticals
P/E Ratio24.8
Return on Equity10.29%
Return on Assets6.13%
52-Week Range₹86.00 – ₹139.65
1-Year Price Change-0.4%
3-Month Price Change+40.7%
Beta (1Y)-0.3
Dividend Yield0.15%
HeadquartersAhmedabad, Gujarat
Websitesotacpharma.com

Shareholding and Delivery

Promoters held 72.85% of Sotac Pharmaceuticals Limited's shares as of Sept 2026, unchanged from Sept 2025.

About Sotac Pharmaceuticals Limited

Sotac Pharmaceuticals Limited engages in the production, manufacturing, processing, and sale of various pharmaceutical products in India. Its therapeutic product portfolio includes anti-diabetic, anti-psychotic, vitamins, minerals, iron supplements, anti-cold, anti-allergic, dermatological solutions, antacid, anti-ulcerants, PPI, anti-emetics, cardiac, anti-hypertensives, analgesic, anti-pyretic, anti-inflammatory, anti-bacterial, anti-viral, general antibiotics, IP-lactams and non-IP-lactams, anti-fungal, and cephalosporin products. The company also offers non-beta lactam general tablets, beta lactam coated tablets, beta lactam uncoated tablets, non-beta lactam general capsules, beta‐lactam capsules, oral liquid, dry syrup and external preparations such as nasal spray, relief spray and creams. In addition, it is involved in the research of pharmaceutical molecules used in developing new pharmaceutical formulations; and manufacture of nutraceuticals and food products. The company also

Products and Services

1. Pharmaceuticals-This segment engages in the manufacturing of a range of pharmaceutical products. 2. NA-NA 3. NA-NA 4. NA-NA

Business Segments

1. Pharmaceuticals-100%

Sotac Pharmaceuticals Limited vs Peers — Pharmaceuticals

CompanyMarket CapP/EROELatest Qtr Revenue1Y Change
Abbott India Ltd.₹56,531 Cr36.334.46%₹1,814 Cr-8.1%
Emcure Pharmaceuticals Ltd₹42,344 Cr47.919.57%₹2,820 Cr+73.3%
Ajanta Pharma Limited₹41,474 Cr39.425.39%₹1,794 Cr+27.8%
Piramal Pharma Ltd₹32,600 Crn/m-4.00%₹2,617 Cr+22.8%
RUBICON RESEARCH LIMITED₹28,526 Cr112.319.14%₹576 Cr+162.7%
Caplin Point Laboratories Ltdte₹18,155 Cr28.319.94%₹630 Cr+23.6%
Pfizer Ltd.₹17,811 Cr24.517.16%₹727 Cr-24.2%
Eris Lifesciences Ltd₹17,691 Cr28.318.07%₹892 Cr-17.5%
Sotac Pharmaceuticals Limited₹144 Cr24.810.29%—-0.4%

Listed by market capitalisation. Ratios are shown for context only.

Frequently Asked Questions

What is the current share price of Sotac Pharmaceuticals Limited?

Sotac Pharmaceuticals Limited is trading at ₹129.35, with a market capitalisation of ₹144 Cr.

Which sector does Sotac Pharmaceuticals Limited belong to?

Sotac Pharmaceuticals Limited operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Biotechnology and Life Sciences > Pharmaceuticals).

What are the key financial ratios of Sotac Pharmaceuticals Limited?

Sotac Pharmaceuticals Limited has a P/E of 24.8 and a return on equity of 10.29%.

What is the stock symbol of Sotac Pharmaceuticals Limited?

Sotac Pharmaceuticals Limited is listed on the NSE under the symbol SOTAC.

How has Sotac Pharmaceuticals Limited's share price moved over the past year?

Sotac Pharmaceuticals Limited's share price is down 0.4% over one year and up 40.7% over three months. Its 52-week range is ₹86.00 to ₹139.65.

What is the promoter holding in Sotac Pharmaceuticals Limited?

Promoters held 72.85% of Sotac Pharmaceuticals Limited's shares as of Sept 2026, unchanged from Sept 2025.

More on FinBizNet

Data as of 16 Nov 2026. Descriptive market data only — not investment advice.